Breaking News

Celonic to Boost Cell & Gene Therapy Production

Will establish a new facility in the upcoming Life Science Park Rheintal in Stein, Switzerland.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Celonic Group, a global contract development and manufacturing organization (CDMO) specialized in development and production of Advanced Therapy Medicinal Products (ATMP) and bio-therapeutics, has entered a long-term lease agreement for a new production site and office space spanning 91,500 square feet (8,500 sqm) in the WST-222 building at the Novartis-operated Life Science Park Rheintal. In this recently-announced life science park in Stein AG (Switzerland), Celonic will establish development ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters